氨基末端脑钠肽前体在川崎病心脏损害时的临床意义  

Clinical Significance of N - terminal Pro - brain Natriuretic Peptide in Heart Injury in Kawasaki Disease

作　　者：周传恩[1] 

机构地区：[1]广东省珠海市妇幼保健院儿内一科,519000

出　　处：《实用心脑肺血管病杂志》2013年第7期80-81,共2页Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease

摘　　要：目的分析氨基末端脑钠肽前体(NT-proNBP)在川崎病心脏损害时的临床意义。方法将在我院诊治的川崎病心脏损害患者40例作为观察组,选择同期35例健康儿童作为对照组,检测两组血浆NT-proNBP水平。结果观察组血浆NT-proNBP水平高于对照组,差异有统计学意义(P<0.05)。结论 NT-proNBP水平可作为辅助诊断川崎病心脏损伤的标志物,有助于疾病及时治疗,避免患者病情进一步加重。Objective To analyze the clinical significance of N-terminal pro-brain natriuretic peptide（NT-proNBP） in heart injury in kawasaki disease.Methods In my hospital for treatment of Kawasaki disease of heart damage in patients with 40 cases as the observation group,select the same period in 35 healthy children as control group,the NT-proNBP levels of two groups of plasma.Results In the observation group,the plasma NT-proNBP level was significantly higher than the control group,the difference was statistically significant（P 0.05）.Conclusion NT-proNBP can be used as auxiliary diagnosis marker for cardiac lesions in Kawasaki disease,contribute to the treatment of the disease in time,avoid patients further aggravate the disease.

关 键 词：黏膜皮肤淋巴结综合征 心脏损害 氨基末端脑钠肽前体 

分 类 号：R551.24[医药卫生—血液循环系统疾病]